Premium
[P1–070]: THE FINANCIAL CAPACITY INSTRUMENT–SHORT FORM IS A NOVEL, PERFORMANCE‐BASED MEASURE THAT MAY HELP DIFFERENTIATE MILD COGNITIVE IMPAIRMENT AND MILD DEMENTIA DUE TO ALZHEIMER's DISEASE POPULATIONS IN CLINICAL TRIALS
Author(s) -
Swanson Chad J.,
Marson Daniel C.,
McPherson Tarrant,
Gerstenecker Adam,
Logovinsky Veronika
Publication year - 2017
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2017.06.137
Subject(s) - dementia , cognitive impairment , disease , medicine , cognition , clinical trial , baseline (sea) , psychology , gerontology , psychiatry , oceanography , geology